Regulators Under Pressure As Illegal Use of Ivermectin to Treat COVID-19 Soars 05/02/2021 Kerry Cullinan CAPE TOWN – The South African police have arrested six people in the past two weeks for trying to smuggle large quantities of the anti-parasitic medicine, ivermectin, into the country from India as demand for the drug as a treatment for COVID-19 surges internationally. Ivermectin is only registered to treat parasitic infections in animals in […] Continue reading -> COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Posts navigation Older postsNewer posts
COVAX To Begin Dispatch Of 90 Million COVID-19 Vaccine Doses To Africa 04/02/2021 Editorial team COVAX aims to start shipping nearly 90 million COVID-19 vaccine doses to the continent this month – in what will be Africa’s largest ever mass vaccination campaign, said WHO Regional Director for Africa Matshidiso Moeti at a press briefing Thursday. COVAX has notified countries in Africa of the estimated dose allocation for the first phase of […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Posts navigation Older postsNewer posts
Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Posts navigation Older postsNewer posts
Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Posts navigation Older postsNewer posts
South Africa’s Second COVID Wave Passes Despite Variant – AstraZeneca Vaccines For Health Workers’ Arrive But At Higher Price Than EU Paid 02/02/2021 Kerry Cullinan CAPE TOWN – Despite battling against a more infectious variant, South Africa seems to have ridden out its second and deadliest wave of COVID-19 infections. And with new case counts declining, the government relaxed its most recent set of lockdown restrictions on Tuesday – reopening beaches, and easing night-time curfews and a ban on alcohol […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Posts navigation Older postsNewer posts
Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Posts navigation Older postsNewer posts
European Union Resolves Dispute With AstraZeneca Over COVID Vaccine Deliveries – EU Officials Predict More Steady Supplies By April 01/02/2021 Madeleine Hoecklin AstraZeneca has agreed to increase its COVID-19 vaccine deliveries to the European Union by 30% after a week of feuding over a shortfall in vaccine deliveries, announced by the pharma company after its manufacturing plants hit a number of snags. By April or June, a series of manufacturing foul-ups reported by Pfizer as well as […] Continue reading -> One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Posts navigation Older postsNewer posts
One Year Later: COVID-19 Versus WHO And The World – Successes, Failures & Hopes 30/01/2021 Elaine Ruth Fletcher “A strange virus is circulating in Wuhan, China,” said my grad school intern, Grace Ren, just back from a visit to her mother in Shanghai in early January, 2020. Somewhere in between the brief respite of New Year’s and a hurried fondue alongside frigid Lake Leman in early February during WHO’s first and last in-person […] Continue reading -> Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Posts navigation Older postsNewer posts
Novavax’s COVID Vaccine Shows High Efficacy In Trials; J&J One-Dose Shot Less So – As Europe Feuds With AstraZeneca 29/01/2021 Madeleine Hoecklin Novavax has become the first COVID-19 vaccine to show clinical efficacy against two major new SARS-CoV-2 virus variants now circulating worldwide – although the vaccine’s highest efficacy of 95.6% was against the COVID strain that had been predominant up until the end of 2020. The results of a UK-based Phase 3 clinical trial, which enrolled […] Continue reading -> COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Posts navigation Older postsNewer posts
COVAX Will Be Able To Give Country Data On Expected COVID Vaccine Allocations Within ‘Next Day’ 29/01/2021 Kerry Cullinan Member countries will have an idea of how many COVID vaccine doses they will receive via the World Health Organization’s COVAX Facility and when they will arrive within the next day, WHO special advisor Dr Bruce Alyward has said. These “indicative allocations” would depend on when the WHO’s regulatory review of the specific vaccines that […] Continue reading -> Posts navigation Older postsNewer posts